BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8165565)

  • 1. The role of autotaxin and other motility stimulating factors in the regulation of tumor cell motility.
    Stracke M; Liotta LA; Schiffmann E
    Symp Soc Exp Biol; 1993; 47():197-214. PubMed ID: 8165565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and transcriptional regulation of the PD-Ialpha/autotaxin gene in neuroblastoma.
    Kawagoe H; Stracke ML; Nakamura H; Sano K
    Cancer Res; 1997 Jun; 57(12):2516-21. PubMed ID: 9192834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.
    Nam SW; Clair T; Kim YS; McMarlin A; Schiffmann E; Liotta LA; Stracke ML
    Cancer Res; 2001 Sep; 61(18):6938-44. PubMed ID: 11559573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive screening assay for secreted motility-stimulating factors.
    Nam SW; Clair T; Schiffmann E; Liotta LA; Stracke ML
    Cell Motil Cytoskeleton; 2000 Aug; 46(4):279-84. PubMed ID: 10962482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells.
    Nam SW; Clair T; Campo CK; Lee HY; Liotta LA; Stracke ML
    Oncogene; 2000 Jan; 19(2):241-7. PubMed ID: 10645002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells.
    Seifert A; Klonisch T; Wulfaenger J; Haag F; Dralle H; Langner J; Hoang-Vu C; Kehlen A
    Oncol Rep; 2008 Jun; 19(6):1485-91. PubMed ID: 18497954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell motility.
    Liotta LA; Stracke ML; Aznavoorian SA; Beckner ME; Schiffmann E
    Semin Cancer Biol; 1991 Apr; 2(2):111-4. PubMed ID: 1912521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on expression of autotaxin mRNA in hepatocellular carcinoma].
    Zhao Z; Xu S; Zhang G
    Zhonghua Gan Zang Bing Za Zhi; 1999 Sep; 7(3):140-1. PubMed ID: 10572678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.
    Black EJ; Clair T; Delrow J; Neiman P; Gillespie DA
    Oncogene; 2004 Mar; 23(13):2357-66. PubMed ID: 14691447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.
    Clair T; Aoki J; Koh E; Bandle RW; Nam SW; Ptaszynska MM; Mills GB; Schiffmann E; Liotta LA; Stracke ML
    Cancer Res; 2003 Sep; 63(17):5446-53. PubMed ID: 14500380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells.
    Lee HY; Murata J; Clair T; Polymeropoulos MH; Torres R; Manrow RE; Liotta LA; Stracke ML
    Biochem Biophys Res Commun; 1996 Jan; 218(3):714-9. PubMed ID: 8579579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases.
    Murata J; Lee HY; Clair T; Krutzsch HC; Arestad AA; Sobel ME; Liotta LA; Stracke ML
    J Biol Chem; 1994 Dec; 269(48):30479-84. PubMed ID: 7982964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities.
    Koh E; Clair T; Woodhouse EC; Schiffmann E; Liotta L; Stracke M
    Cancer Res; 2003 May; 63(9):2042-5. PubMed ID: 12727817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophospholipids in the limelight: autotaxin takes center stage.
    Moolenaar WH
    J Cell Biol; 2002 Jul; 158(2):197-9. PubMed ID: 12135981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation and regulation of tumor cell motility in invasion and metastasis.
    Levine MD; Liotta LA; Stracke ML
    EXS; 1995; 74():157-79. PubMed ID: 8527892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of fibroblast-like synoviocytes with IFN-gamma results in the down-regulation of autotaxin mRNA.
    Santos AN; Riemann D; Santos AN; Kehlen A; Thiele K; Langner J
    Biochem Biophys Res Commun; 1996 Dec; 229(2):419-24. PubMed ID: 8954913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotaxin is an N-linked glycoprotein but the sugar moieties are not needed for its stimulation of cellular motility.
    Stracke ML; Arestad A; Levine M; Krutzsch HC; Liotta LA
    Melanoma Res; 1995 Aug; 5(4):203-9. PubMed ID: 7496154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein.
    Stracke ML; Krutzsch HC; Unsworth EJ; Arestad A; Cioce V; Schiffmann E; Liotta LA
    J Biol Chem; 1992 Feb; 267(4):2524-9. PubMed ID: 1733949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide binding to autotaxin: crosslinking of bound substrate followed by lysC digestion identifies two labeled peptides.
    Clair T; Krutzsch HC; Liotta LA; Stracke ML
    Biochem Biophys Res Commun; 1997 Jul; 236(2):449-54. PubMed ID: 9240459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.
    Hasina R; Matsumoto K; Matsumoto-Taniura N; Kato I; Sakuda M; Nakamura T
    Br J Cancer; 1999 Aug; 80(11):1708-17. PubMed ID: 10468286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.